This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Celesio, Sainsbury’s pharmacy deal faces in-depth probe in UK

( December 11, 2015, 16:32 GMT | Official Statement) -- MLex Summary: The UK’s Competition and Markets Authority has said it will refer to an in-depth probe plans by Celesio, the owner of Lloyds Pharmacy, to buy the pharmacy business of supermarket chain Sainsbury’s. While the price of prescription medicines is regulated in the UK, the watchdog is worried about how the deal would affect factors such as customer choice and service.The full statement follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login